CSR Chemotherapy Welfare Fund
Breast cancer is the most common type of cancer found in Malaysia. Around 5,000 Malaysian women are diagnosed with breast cancer every year, most of them aged between 30 and 60 years, and nearly half of those affected are under 50-years of age.
Chemotherapy is a treatment for breast cancer using anti-cancer (also called cytotoxic) drugs. The aim is to stop cancer cells from continuing to divide uncontrollably. Cancer cells grow by dividing in a disorderly and uncontrolled way. Chemotherapy gets in the form of their ability to share and grow. Different chemotherapy drugs work in different ways and affect the cancer cells to varying phases of their growth. This is why a combination of drugs is often used.
The cost of cancer treatment has been rising in recent year, making them unaffordable for low-income patients. It is difficult for patients who are having financial challenged to start their treatment due to the cost. For others, affording the cost of follow-up care can be a problem after their first treatment. The rising cost may cause some patients to skip or delay their treatment and put their chance of survival in jeopardy.
Under normal circumstances, the cost of chemotherapy treatment can reach up to RM4,000 – RM6,000 per cycle, and patients require 4 – 8 cycles of treatment. Under the Breast Cancer Chemotherapy Welfare Fund program, patients are required to pay about 10% of the charges. Beacon Hospital will subsidize the balance. This CSR program is intended to support the patient’s chemotherapy treatment for pre-selected chemotherapy protocols.
To apply for this Chemotherapy Therapy Welfare Fund, patients can enquire at Beacon Hospital or approach any participating NGOs and supporting groups for further information. Interested applicants may apply by seeking advice from our CSR officer via phone call to +6011-1090 6588 or email to firstname.lastname@example.org.
- Open to Malaysian citizens who are diagnosed with early stage breast cancer.
- Once the treatment plan is established, the attending oncologist will then refer the case to Beacon’s CSR office for financial assessment and eligibility.
- Patients who are low income, financially challenged, exhausted their finances or insufficient insurance coverage.
- Patients are required to consult oncologist as an outpatient (consultation charges apply) in Beacon Hospital.
- The attending oncologist will then refer the case to Beacon’s CSR office for financial assessment and eligibility.
- It will take approximately 1 – 2 working days to process the application.
- Once the application is approved, the patient will be provided with a guarantee letter, which will enable the patient to get the treatment done at the agreed subsidized cost.
Terms & Conditions
- This program is open to Malaysian citizens only.
- This program is applicable to low income patients who are diagnosed with early stage breast cancer.
- Applicants are required to fill up application form and submit with supporting documents to CSR department for assessment and approval.
- Beacon Hospital Sdn Bhd reserves the rights to amend the terms & conditions anytime without prior notice.